Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres

Barcelonabeta Brain Research Center, Pasqual Maragall Foundation231 enrolled

Overview

An experimental study designed to test the effectiveness of a psychological intervention based on group therapy for the caregivers of Alzheimer's disease patients. The intervention consists of 16 sessions of a cognitive-behavioral psychological group therapy. This study aims to demonstrate that Alzheimer's patients' caregivers can decrease the feelings of burden after been involved in a group therapy.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

231

Conditions

Alzheimer's Disease

Interventions

Psychotherapy groupsBEHAVIORAL

Self-help groupsBEHAVIORAL

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Main caregiver of an Alzheimer Disease Patient. * Alzheimer Disease Patient with mild/severe cognitive impairment. * High compliance to therapy sessions. * Sign informed consent. Exclusion Criteria: * Low commitment to develop all study phases. * Caregiver activity remunerated. * Caregiver with psychiatric disorders that can affect the development of the sessions. * Caregivers who have received psychological care during last year.

Locations (11)

AFA Barcelona

Barcelona, Spain

Centro de día Vitalia

Barcelona, Spain

AFA Burgos

Burgos, Spain

AFA Castellón

Castellon, Spain

Outcomes

Primary Outcomes

Efficacy of group therapy in caregiver burden measured by Zarit Burden Interview.

Time frame: 16 months

Secondary Outcomes

Change in caregiver burden from baseline compared to the control and active arms measured by Zarit Burden Interview.

Time frame: 4 months and 16 months

Change in anxiety and depression from baseline compared to the control and active arms measured by Goldberg Scale.

Time frame: 4 months and 16 months

Descriptive analysis of the caregivers' characteristics (sociodemographics, relation wih the AD patient).

Time frame: Baseline (0 months)

Descriptive analysis of the caregiver's cognition using DEM-DETECT Module 1.

Time frame: 4 months

Preliminary cost-effectiveness analysis related resources needed to caregivers and Alzheimer patients.

Time frame: 4 months - 16 months

Change in quality of life from baseline compared to the control and active arms measured by Casp-19 and SF-36 questionnaires.

Time frame: 4 months - 16 months

Change in resilience from baseline compared to the control and active arms measured by Connor-Davidson Resilience Scale.

Time frame: 4 months - 16 months

Change in functional social support from baseline compared to the control and active arms using Duke-UNC questionnaire.

Time frame: 4 months - 16 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.